You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Healthcare stocks have underperformed in 2023, but that is expected to change this year.
In this video, I will go over four healthcare stocks that represent different exposures to the healthcare industry. One of the companies I cover happens to be the fifth-largest player in the healthcare plans industry, Humana (HUM -1.77%).
*Stock prices used were from the trading day of Jan. 12, 2024. The video was published on Jan. 16, 2024.
Neil Rozenbaum has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbCellera Biologics. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
